Until now, the most effective GLP-1 weight loss treatments have mainly been weekly injections, which can put some patients off due to needle anxiety, inconvenience or stigma
Future research on methylene blue may uncover new applications and further elucidate its mechanisms of action
Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I, Mosenzon O, Rubino DM, Thomsen M, Wadden TA, Pedersen SD
Compounded injectable semaglutide GLP-1 has been widely available for awhile, he noted, yet Eli Lilly has been beating numbers and just put up a huge Q4 beat this week by 10% on Zepbound alone, he wrote in a note
Yesvomiting is a well-documented gastrointestinal side effect reported in clinical trials and FDA prescribing information
That means patients with obesity can't just rely on changing their lifestyle to get better they need treatments to address the life-threatening consequences of their disease